CIK 0001832038 · <br>Emerging growth company
Invivyd, Inc.
Sign in to watch- Ticker
- IVVD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851403134
- Phone
- (781) 819-0080
- Business address
- 205 CHURCH STREET, NEW HAVEN, CT
- Former names
- Adagio Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $177,089
- in 5 filings, $177K under 10b5-1 plans
Net −$177,089. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Andersen Jill −$53K Chief Legal Officer, Secretary sold 19% of stake
- Duke William E. −$32K Chief Financial Officer sold 19% of stake
- Green Julie −$32K Chief Human Resources Officer sold 19% of stake
- Lee Timothy Edward −$32K Chief Commercial Officer sold 19% of stake
- Allen Robert D. III −$29K Chief Scientific Officer sold 17% of stake
Reading 22 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-20 | Lindenboom Christine Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2025-05-20 | Royan Ajay Director | Grant or award · Stock Option (Right to Buy) | +8,219 | 8,219 | ||
| 2025-03-24 | Royan Ajay Director | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2025-02-15 | Andersen Jill Chief Legal Officer, Secretary | Grant or award · Stock Option (Right to Buy) | +950,000 | 950,000 | ||
| 2025-02-15 | Andersen Jill Chief Legal Officer, Secretary | Grant or award · Restricted Stock Units | +500,000 | 500,000 | ||
| 2025-02-15 | Allen Robert D. III Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +950,000 | 950,000 | ||
| 2025-02-15 | Allen Robert D. III Chief Scientific Officer | Grant or award · Restricted Stock Units | +300,000 | 300,000 | ||
| 2025-02-15 | Duke William E. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +950,000 | 950,000 | ||
| 2025-02-15 | Duke William E. Chief Financial Officer | Grant or award · Restricted Stock Units | +300,000 | 300,000 | ||
| 2025-02-15 | Green Julie Chief Human Resources Officer | Grant or award · Stock Option (Right to Buy) | +950,000 | 950,000 | ||
| 2025-02-15 | Green Julie Chief Human Resources Officer | Grant or award · Restricted Stock Units | +300,000 | 300,000 | ||
| 2025-02-15 | Lee Timothy Edward Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +950,000 | 950,000 | ||
| 2025-02-15 | Lee Timothy Edward Chief Commercial Officer | Grant or award · Restricted Stock Units | +300,000 | 300,000 | ||
| 2024-12-31 | MCGUIRE TERRANCE Director | Sale | −103,474 | $0.45 | $46K | 3,066,757 |
| 2024-12-30 | MCGUIRE TERRANCE Director | Sale | −86,545 | $0.48 | $42K | 3,170,231 |
| 2024-12-27 | MCGUIRE TERRANCE Director | Sale | −83,744 | $0.52 | $44K | 3,256,776 |
| 2024-12-26 | MCGUIRE TERRANCE Director | Sale | −83,817 | $0.54 | $46K | 3,340,520 |
| 2024-12-24 | MCGUIRE TERRANCE Director | Sale | −68,161 | $0.51 | $35K | 3,424,337 |
| 2024-12-23 | MCGUIRE TERRANCE Director | Sale | −75,776 | $0.45 | $34K | 3,492,498 |
| 2024-12-20 | MCGUIRE TERRANCE Director | Sale | −119,805 | $0.42 | $51K | 3,568,274 |
Page 5 of 9 · 161 trades